Patent directory · USPTO A61K / A61P
Patents matching “anti-”
1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11999773
Anti-BCMA chimeric antigen receptors
granted -
US 11993655
Anti-PD-L1 antibody and use thereof
granted -
US 11993658
Anti-BCMA antibodies and treatment methods
granted -
US 11993573
Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents
granted -
US 11981730
Anti-CXCL13 antibodies and methods of using the same
granted -
US 11981741
Humanized anti-CD45 antibodies
granted -
US 11976122
Anti-IL13Rα2 antibodies
granted -
US 11974980
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 11970543
Anti-CD39 antibodies and use thereof
granted -
US 11964985
Anti-cancer compounds targeting Ral GTPases and methods of using the same
granted -
US 11965032
Anti-CD20 antibody compositions
granted -
US 11958901
Anti-CXCR5 antibodies and compositions and uses thereof
granted -
US 11958894
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11952365
Anti-viral compounds
granted -
US 11952427
Anti-CD40 antibodies and uses thereof
granted -
US 11951131
Anti-SLAMF7 chimeric antigen receptors
granted -
US 11945872
Anti-ACVR1 antibodies and uses thereof
granted -
US 11944644
T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof
granted -
US 11945824
Heterocyclic compounds as anti-viral agents
granted -
US 11938226
Abiotic anti-VEGF nanoparticle
granted -
US 11938192
Dosage regimes for the administration of an anti-CD19 ADC
granted -
US 11932703
Anti-ROR1 antibody and ROR1-targeting engineered cells
granted -
US 11932606
Anti-cancer/anti-fibrosis compounds
granted -
US 11932698
Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof
granted